News about Market

Archimedis Digital Report Finds Indian Pharma Accelerating Digital Transformation of Quality Systems

A study by Archimedis Digital shows Indian pharma companies increasingly adopting cloud, automation and AI-driven quality systems, though digital maturity remains uneven across organisations transitioning from paper-based processes.

Market | 06/03/2026 | By News Bureau |  351

Octane Medical Group to Acquire Personalised Medicine Unit from Lonza

Octane Medical Group has signed an agreement to acquire the personalised medicine business of Lonza, including the Cocoon cell-therapy platform. The deal aims to expand Octane’s capabilities in advanced therapies and strengthen its presence in the rapidly growing personalised medicine sector.

Market | 06/03/2026 | By News Bureau |  298

Akeso and Inovio Pharmaceuticals Partner to Develop Combination Therapy for Glioblastoma

Akeso and Inovio Pharmaceuticals have entered into a clinical collaboration to evaluate cadonilimab with INO-5412 in glioblastoma. The combination will be studied in the phase-II INSIGhT trial sponsored by Dana-Farber Cancer Institute, building on prior positive data.

Market | 05/03/2026 | By Akanki |  209

GSK completes acquisition of RAPT Therapeutics

GSK has completed the acquisition of RAPT Therapeutics, adding ozureprubart, a long-acting anti-IgE monoclonal antibody, to its pipeline. The candidate is currently in phase-II(b) development for prophylactic protection against food allergens, strengthening GSK’s immunology portfolio.

Market | 05/03/2026 | By Akanki |  238

Ono Pharmaceutical Partners with Congruence Therapeutics for Neurology and Immunology Drug Discovery

Ono Pharmaceutical has expanded its collaboration with Congruence Therapeutics, leveraging the Revenir platform to discover small molecule modulators in neurology and immunology. Ono will hold exclusive worldwide option rights for development and commercialisation of resulting candidates.

Market | 03/03/2026 | By Akanki |  211

Strategic Licensing Boost: Emcure Gains Commercial Rights for Roche Brands in India

Under the agreement, Emcure will acquire commercial rights to several branded prescription medicines used in the management of kidney diseases and in post-transplant care for patients in India. The deal strengthens Emcure’s presence in high-priority therapeutic areas and expands its portfolio in nephrology and transplant medicine.

Market | 03/03/2026 | By Darshana |  395

SciBase Holding AB Secures US FDA Approval to Expand Nevisense Use Beyond Dermatologists

U.S. Food and Drug Administration clears expanded labelling for Nevisense, enabling trained healthcare professionals to perform procedures, improving clinic workflow integration and supporting broader melanoma diagnostic access across the United States.

Market | 03/03/2026 | By News Bureau |  151

Cipla Launches Saxenda for Weight Management

Cipla has strengthened its US portfolio with the launch of a generic version of Saxenda (liraglutide injection), indicated for chronic weight management. The launch follows ANDA approval from the US Food and Drug Administration (FDA), granted to its partner Orbicular, paving the way for expanded access to a more affordable GLP-1 therapy in the US.

Market | 02/03/2026 | By News Bureau |  282

IISc-Led Pravriddhi Backs Indigenous Compressor Technology for Quality-Critical Industries

Pravriddhi, the pan-India product accelerator led by the Foundation for Science Innovation and Development (FSID) at the Indian Institute of Science (IISc), Bengaluru, has announced the launch of India’s first oil-free water-injected screw compressor, HYDRINO.

Market | 27/02/2026 | By Darshana |  131

Lupin Limited Secures US FDA Approval for Generic Brivaracetam Oral Solution

Lupin has received US FDA approval for its generic brivaracetam oral solution, bioequivalent to Briviact, and has launched the product in the US market targeting partial-onset seizures.

Market | 25/02/2026 | By News Bureau |  373